Tag: underwriting

PHARMACISTS MUTUAL WELCOMES FORMER AM BEST PRESIDENT AND CEO MATTHEW MOSHER TO BOARD OF DIRECTORS

ALGONA, Iowa, July 24, 2025 /PRNewswire/ -- Pharmacists Mutual Insurance Company today announced the appointment of Matthew Mosher, former President and CEO of AM...

Amalgamated Financial Corp. Reports Second Quarter 2025 Financial Results; Solid Deposit and Loan Growth; Strong Margin at 3.55%

Common Equity Tier 1 Capital Ratio of 14.13% | Tangible Book Value per Share of $24.33

Linkhome Holdings Inc. Announces Pricing of Upsized $6,000,000 Initial Public Offering

Irvine, CA, July 24, 2025 (GLOBE NEWSWIRE) -- Linkhome Holdings Inc. (“Linkhome” or the “Company”) (Nasdaq: LHAI), a leading AI-powered real estate platform leveraging artificial intelligence and fintech to make homeownership simpler, faster, and more accessible for all Americans, today announced the pricing of its upsized initial public offering (the “Offering”). The Offering consists of 1,500,000 shares of common stock priced at a public offering price of $4 per share, for total gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses. The shares of common stock have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on Jul 24, 2025, under the ticker symbol “LHAI.”

Northfield Bancorp, Inc. Announces Second Quarter 2025 Results

NOTABLE ITEMS FOR THE QUARTER INCLUDE:

Five Star Bancorp Announces Second Quarter 2025 Results

Abivax Announces Launch of Public Offering

Abivax Announces Launch of Public Offering

Sands Point Risk Announces Its Acquisition of BRM Specialty Markets

JERSEY CITY, N.J., July 23, 2025 /PRNewswire/ -- Sands Point Risk, a multi-program MGA platform backed by Avesi Partners, is pleased to announce its acquisition...

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20.00 per share and (ii) to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $19.99 per pre-funded warrant, which represents the per share public offering price for the ordinary shares less the $0.01 per share exercise price for each such pre-funded warrant. All shares and pre-funded warrants in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $175 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about July 24, 2025, subject to satisfaction of customary closing conditions.

Cre8 Enterprise Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq

Hong Kong, July 22, 2025 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (the “Company”), a Hong Kong-based integrated financial printing service provider, today announced the pricing of its initial public offering (the “Offering”) of 1,450,000 Class A ordinary shares (the “Class A Ordinary Shares”) on July 22, 2025, at a price of $4.00 per Class A Ordinary Share (the “Offering Price”).

Timbercreek Financial Declares July 2025 Dividend

TORONTO, July 22, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on August 15, 2025 to holders of Common Shares of record on July 31, 2025.

Dreamland Limited Announces Pricing of Initial Public Offering

HH Fund Announces Successful Disposition of HH Midtown, a Premier Student Housing Asset near major Universities, and Continued Management of the Property

SILVER SPRING, Md., July 22, 2025 (GLOBE NEWSWIRE) -- HH Fund, a leading private equity real estate firm focused on U.S. student housing with over 8,000 beds under management, announced today the successful sale of HH Midtown, a student housing asset, located in Baltimore, Maryland. The single-asset transaction, consisting of 114 units and 323 beds with two retail spaces, closed for an undisclosed price.

Chestnut Carbon Announces Pioneering Non-Recourse Project Financing for U.S. Afforestation in the Voluntary Carbon Market

Led by J.P. Morgan, this facility represents a significant step towards scalability for nature-based carbon projects. NEW YORK, July 22, 2025 /PRNewswire/ -- Chestnut Carbon...

Empower Finance Acquires NIRA to Accelerate Credit Access in India’s Underserved Markets

SAN FRANCISCO and BENGALURU, India, July 22, 2025 /PRNewswire/ -- Empower Finance Inc., a U.S.-based fintech company focused on expanding access to credit for...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsUnderwriting

HorseWood & HorseBoost [Exclusive Report 2026] The Horse Gelatin Trick Male Enhancement Or Why Talking About Natural Vitality Supplement Horse Boost?

Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Via Transportation, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VIA